DMCC Speciality Chemicals Q1 Results: Net Profit Surges to ₹2,040.52 Lakhs YoY
DMCC Speciality Chemicals Limited reported its unaudited Q1 FY27 results for the quarter ended June 30, 2026, with standalone total income from operations more than doubling to ₹25,329.33 lakhs from ₹12,729.76 lakhs YoY. Standalone net profit after tax surged to ₹2,040.52 lakhs compared to ₹775.31 lakhs in the year-ago quarter, while basic and diluted EPS rose to ₹8.18 from ₹3.11. Consolidated results were in line with standalone performance, with net profit after tax at ₹2,040.52 lakhs. The results were approved by the Board of Directors on August 10, 2026, following a limited review by statutory auditors.

*this image is generated using AI for illustrative purposes only.
DMCC Speciality Chemicals Limited reported a significant year-on-year improvement in its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's standalone total income from operations more than doubled to ₹25,329.33 lakhs from ₹12,729.76 lakhs in the corresponding quarter of the previous year, reflecting robust growth in its chemicals manufacturing and sales segment. The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 10, 2026, and have been prepared in accordance with Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013.
Standalone Financial Performance
The standalone financial results for the quarter ended June 30, 2026 demonstrate a strong recovery and growth trajectory across all key profitability metrics. Net profit before tax stood at ₹2,721.14 lakhs, compared to ₹1,102.66 lakhs in Q1 of the prior year. Net profit after tax came in at ₹2,040.52 lakhs, a substantial increase from ₹775.31 lakhs in the year-ago quarter. Total comprehensive income for the period was ₹1,997.91 lakhs versus ₹716.75 lakhs in the prior year quarter.
The following table summarises the standalone financial results:
| Metric: | Q1 FY27 (30.06.2026) Unaudited | Q4 FY26 (31.03.2026) Audited | Q1 FY26 (30.06.2025) Unaudited | FY26 Year Ended (31.03.2026) |
|---|---|---|---|---|
| Total Income from Operations (₹ Lakhs): | 25,329.33 | 17,779.23 | 12,729.76 | 58,296.23 |
| Net Profit before Tax (₹ Lakhs): | 2,721.14 | 1,082.13 | 1,102.66 | 3,896.23 |
| Net Profit after Tax (₹ Lakhs): | 2,040.52 | 766.40 | 775.31 | 2,733.18 |
| Total Comprehensive Income (₹ Lakhs): | 1,997.91 | 761.90 | 716.75 | 2,673.18 |
| Equity Share Capital (₹ Lakhs): | 2,493.99 | 2,493.99 | 2,493.99 | 2,493.99 |
| Basic & Diluted EPS (₹): | 8.18 | 3.07 | 3.11 | 10.96 |
Consolidated Financial Performance
On a consolidated basis, the company's performance closely mirrored the standalone results. Total income from operations for the quarter ended June 30, 2026 stood at ₹25,330.97 lakhs, compared to ₹12,741.73 lakhs in the year-ago quarter. Consolidated net profit after tax was ₹2,040.52 lakhs versus ₹775.52 lakhs in Q1 of the prior year. Total comprehensive income on a consolidated basis was ₹1,997.91 lakhs for the current quarter.
The following table presents the consolidated financial highlights:
| Metric: | Q1 FY27 (30.06.2026) Unaudited | Q4 FY26 (31.03.2026) Audited | Q1 FY26 (30.06.2025) Unaudited | FY26 Year Ended (31.03.2026) |
|---|---|---|---|---|
| Total Income from Operations (₹ Lakhs): | 25,330.97 | 17,780.38 | 12,741.73 | 58,261.31 |
| Net Profit before Tax (₹ Lakhs): | 2,721.14 | 1,081.14 | 1,102.97 | 3,896.24 |
| Net Profit after Tax (₹ Lakhs): | 2,040.52 | 765.41 | 775.52 | 2,732.87 |
| Total Comprehensive Income (₹ Lakhs): | 1,997.91 | 763.17 | 715.97 | 2,682.93 |
| Equity Share Capital (₹ Lakhs): | 2,493.99 | 2,493.99 | 2,493.99 | 2,493.99 |
| Other Equity (₹ Lakhs): | — | — | 22,276.42 | 22,323.74 |
| Basic & Diluted EPS (₹): | 8.18 | 3.07 | 3.11 | 10.96 |
Key Notes and Disclosures
Several notable disclosures accompanied the quarterly results:
- The company operates in a single segment—manufacturing and sale of chemicals—and therefore segment-wise disclosure requirements under Ind AS 108 on Operating Segments are not applicable.
- The statutory auditors conducted a limited review of the financial results for the quarter ended June 30, 2026 and issued an unmodified review opinion.
- The figures for the quarter ended March 31, 2026 represent balancing figures between the audited full-year figures and the unaudited nine-month figures ended December 31, 2025.
- The full format of the financial results is available on the websites of BSE Limited, the National Stock Exchange of India Ltd., and the company's website.
The results were signed off by Bimal Latesh Goudsal, Managing Director & Chief Executive Officer (DIN: 00242783), at Mumbai on August 10, 2026.
Historical Stock Returns for DMCC Speciality Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.55% | +8.63% | +14.57% | +24.03% | -9.58% | -1.29% |
What specific operational drivers or product mix changes contributed to the doubling of revenue, and are these growth factors sustainable for the remainder of FY27?
How does the company plan to manage input cost volatility in the specialty chemicals sector to protect the expanded profit margins observed in Q1?
Given the significant year-on-year improvement, what is the management's guidance on capital expenditure or capacity expansion plans to capitalize on this demand surge?


































